For example, instead of a pill, they make a capsule. Or instead of a dose every six hours, they create a longer-acting, once-a-day version. They can also alter the process by which a drug is made — so ...

Take the case of Humira, the AbbVie AbbVie arthritis drug that reached $20 billion in annual sales. Humira’s core composition of matter patent expired in 2016, and “biosimilar” generic ...

BioNxt Solutions (TSE:BNXT) has released an update.BioNxt Solutions Inc. has embarked on the nationalization process for its patents related to the sublingual delivery of anticancer drugs, aiming ...

An analysis of patent applications for 10 top-selling prescription drugs found that nearly three-quarters of them were filed after FDA approval, a cross-sectional study of U.S. patent thickets found.

The court concluded that Regs. Sec. 1.263(a)-4 did not require capitalization of the litigation expenses. “The legal expenses incurred — which originate from the branded drug companies’ patent ...

These can include patents on the manufacturing process, formulation, how the drug is administered, and even the devices used for delivery. Biosimilar manufacturers in the US face a complex legal ...

In Mylan, Inc., 76 F.4th 230 (3d Cir. 2023), the Third Circuit affirmed the Tax Court’s opinion that patent infringement litigation expenses resulting from abbreviated new drug application (ANDA) ...

We will discuss recent guidance from the U.S. Patent and Trademark Office (USPTO) and dive into questions that the field is just beginning to consider as the number of AI-assisted patent ...

They can also alter the process by which a drug is made — so-called “process patents.” Each tweak gets a new patent, which the manufacturer then adds to its official compendium of drug patents.